Trilaciclib is named as a drug or biological intervention in 10 clinical trials in our China and USA trial registers, 7 of which are recruiting. Lead sponsors include Sun Yat-sen University (3), Pharmacosmos A/S (1) and Henan Cancer Hospital (1). Registered phases: Phase 2, Phase 3 and Observational. Conditions studied include Non-Small Cell Lung Cancer; Breast Cancer; Myelosuppression.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Non-Small Cell Lung Cancer | 2 |
| Breast Cancer | 2 |
| Myelosuppression | 2 |
| Limited Stage Small Cell Lung Cancer | 1 |
| Endometrial Cancer | 1 |
| Cervical Cancer | 1 |
| Non-small Cell Lung Cancer | 1 |
| DLBCL | 1 |
| ESCC | 1 |
| Ewing Sarcoma | 1 |
| Head and Neck Cancer Squamous Cell Carcinoma | 1 |
| Osteosarcoma | 1 |
| Lead sponsor | Trials |
|---|---|
| Sun Yat-sen University | 3 |
| Pharmacosmos A/S | 1 |
| Henan Cancer Hospital | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
| Fudan University | 1 |
| The First Affiliated Hospital of Xiamen University | 1 |
| Hunan Cancer Hospital | 1 |
| Peking University People's Hospital | 1 |
| Register | Trilaciclib trials |
|---|---|
| Clinical trials in China | 9 |
| Clinical trials in USA | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Trilaciclib works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Trilaciclib (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.